When the heart's largest valve leaks, complications can arise. A progressive form of the condition tricuspid regurgitation is considered among the toughest heart valve conditions to treat. Laplace Interventional is developing a novel solution that does not require open-heart surgery, reducing the possibility of future complications in patients. The company's prosthetic valve can be delivered through a minimally invasive procedure, with a goal of increased life expectancy and improved quality of life.

Doctors are already praising the technology as easy to use with the potential to improve the lives of millions worldwide.